Cardiac Biotech Solutions, Inc. (CBSC)
0.04
0.00 (0.00%)
USD |
OTCM |
Feb 27, 16:00
Cardiac Biotech Solutions Enterprise Value : 7.097M for Feb. 27, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Delcath Systems, Inc. | 218.73M |
| Quest Diagnostics, Inc. | 29.44B |
| Danaher Corp. | 164.04B |
| CytoSorbents Corp. | 67.14M |
| Odyssey Health, Inc. | 5.782M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.5737M |
| Revenue (Quarterly) | 0.0403M |
| Total Expenses (Quarterly) | 0.614M |
| EPS Diluted (Quarterly) | -0.0035 |
| Profit Margin (Quarterly) | -1.42K% |
| Earnings Yield | -31.25% |
| Normalized Earnings Yield | -29.75 |